Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1994-7-13
|
pubmed:databankReference | |
pubmed:abstractText |
We have previously identified a Plasmodium falciparum liver stage-specific Ag (LSA-1) found to encode tandem 17 amino acid repeats harboring B cell determinants. Here we extend this study in terms of sequence analysis, protein localization, and immunologic properties. Analysis of the N- and C-terminal regions of LSA-1 from the T9/96 clone reveals high sequence conservation with LSA-1 from NF54. This 200-kDa protein is detected throughout liver schizogony and accumulates in the parasitophorous vacuole space. In our investigation of T and B cell responses to LSA-1, we have focused on both the area of the C-terminal, nonrepetitive "hinge" region and the conserved repetitive region and derived synthetic peptides. These were found to contain major B and T cell determinants. High prevalences and elevated Ab levels to LSA-1, directed primarily, although not exclusively, to the repetitive region, were detected in sera of individuals from one moderately high and two low transmission malaria-endemic areas (prevalences of 97%, 75, and 77%, respectively). In one of these low transmission areas, secretion of the cytokine IFN-gamma, known to inhibit malaria liver stages, and T cell proliferation were detected in PBMC of 22 to 48% and 6 to 20%, respectively, of individuals in response to separate LSA-1 peptides. These results complement the recent finding of conserved CTL epitopes in LSA-1 and support the assertion that immune responses to LS Ag are involved in protection against malaria pre-erythrocytic stages.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
190-204
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7515922-Amino Acid Sequence,
pubmed-meshheading:7515922-Animals,
pubmed-meshheading:7515922-Antigens, Protozoan,
pubmed-meshheading:7515922-B-Lymphocytes,
pubmed-meshheading:7515922-Base Sequence,
pubmed-meshheading:7515922-Circular Dichroism,
pubmed-meshheading:7515922-Epitopes,
pubmed-meshheading:7515922-Genes, Protozoan,
pubmed-meshheading:7515922-Humans,
pubmed-meshheading:7515922-Liver,
pubmed-meshheading:7515922-Lymphocyte Activation,
pubmed-meshheading:7515922-Malaria, Falciparum,
pubmed-meshheading:7515922-Molecular Sequence Data,
pubmed-meshheading:7515922-Plasmodium falciparum,
pubmed-meshheading:7515922-Protein Structure, Secondary,
pubmed-meshheading:7515922-Solubility,
pubmed-meshheading:7515922-T-Lymphocytes
|
pubmed:year |
1994
|
pubmed:articleTitle |
Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants.
|
pubmed:affiliation |
Bio-Medical Parasitology Laboratory, Pasteur Institute, Paris, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|